Cargando…

Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids

BACKGROUND: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflaza...

Descripción completa

Detalles Bibliográficos
Autor principal: Parente, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216559/
https://www.ncbi.nlm.nih.gov/pubmed/28057083
http://dx.doi.org/10.1186/s40360-016-0111-8
_version_ 1782491936029933568
author Parente, Luca
author_facet Parente, Luca
author_sort Parente, Luca
collection PubMed
description BACKGROUND: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature. MAIN BODY: This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort. SHORT CONCLUSION: We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice.
format Online
Article
Text
id pubmed-5216559
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52165592017-01-09 Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids Parente, Luca BMC Pharmacol Toxicol Debate BACKGROUND: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature. MAIN BODY: This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort. SHORT CONCLUSION: We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice. BioMed Central 2017-01-05 /pmc/articles/PMC5216559/ /pubmed/28057083 http://dx.doi.org/10.1186/s40360-016-0111-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Parente, Luca
Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
title Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
title_full Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
title_fullStr Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
title_full_unstemmed Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
title_short Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
title_sort deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216559/
https://www.ncbi.nlm.nih.gov/pubmed/28057083
http://dx.doi.org/10.1186/s40360-016-0111-8
work_keys_str_mv AT parenteluca deflazacorttherapeuticindexrelativepotencyandequivalentdosesversusothercorticosteroids